Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033
Published February 6, 2013 · Recall initiated: December 12, 2012
Summary
FDA records drug Class II recall D-139-2013, published February 6, 2013 and initiated December 12, 2012. Recalling firm: Schering-Plough Products, LLC; Status: Terminated; Reported quantity: 17,169 Packages; Lot: Lot: 0NCW005, Exp 02/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Schering-Plough Products, LLC
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot: 0NCW005, Exp 02/2013
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydrocodone bitartrate and acetaminophen Tablets, USP, 10 mg/500 mg, packaged in a) 30-count bottles, NDCFebruary 6, 2013
- FDAHILLYARD, Alcohol Free Foaming Instant Hand Sanitizer, Benzalkonium Chloride 0.10%, 1.25 L plastic bottle,February 6, 2013
- FDACarvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc.,February 6, 2013
- FDAFemtrace 0.9 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics InternationalFebruary 6, 2013
- FDAFemtrace 0.45 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by PharmaceuticsFebruary 6, 2013
- FDAUltraClean(R) Accessory Electrode 4 inch Coated Blade with Extended Insulation, REF/Catalog No. 139112EXT,January 30, 2013
Questions about this recall
Was Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033 recalled?
Yes. FDA published recall D-139-2013 on February 6, 2013. Reported hazard: Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.
What should I do if I have this product?
Voluntary: Firm initiated · Letter